Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2093868 Target Snapshot

Dopamine receptor · PROTEIN FAMILY · Rattus norvegicus

756Compounds
184Assays
22Approved Drugs
678.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P25115. Use UniProt P25115 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P25115 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dopamine receptor as ChEMBL target CHEMBL2093868, mapped to UniProt P25115. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dopamine receptor
PROTEIN FAMILY · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2093868
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P25115
D(1B) dopamine receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dopamine receptor is the right protein anchor across sources, using UniProt P25115 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelD(1B) dopamine receptor
UniProt AccessionP25115
Component TypeProtein
Sequence Length475 aa

D(1B) dopamine receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dopamine receptor, mapped to UniProt P25115. ChEMBL maps the protein component as D(1B) dopamine receptor. Sequence length is 475 aa.

Mapped IDP25115
Review nameDopamine receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

22
Approved
3
Phase III
14
Phase II
Assay Mix

Activity Type Distribution

IC50556.0
KI121.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1788212 10.47 Ki 0.034 Preclinical
CHEMBL1255588 9.7 Ki 0.2 Preclinical
CHEMBL544618 9.64 Ki 0.23 Preclinical
CHEMBL54 9.55 IC50 0.28 Approved
CHEMBL38428 9.49 IC50 0.32 Preclinical
CHEMBL1204189 9.48 Kd 0.3337 Preclinical
CHEMBL1423 9.4 IC50 0.4 Approved
CHEMBL295712 9.21 IC50 0.61 Preclinical
CHEMBL8946 9.04 IC50 0.92 Clinical
CHEMBL53 9.0 IC50 1.0 Approved
Distribution

pChEMBL Value Distribution

42
5.0
54
5.5
81
6.0
83
6.5
88
7.0
108
7.5
56
8.0
34
8.5
8
9.0
3
9.5
pChEMBL
Approved Drugs

Approved Drugs

APOMORPHINE
CHEMBL53
Approved 2001
DEXMETHYLPHENIDATE HYDROCHLORIDE
CHEMBL904
Approved 2001
APOMORPHINE HYDROCHLORIDE
CHEMBL3187985
Approved 2001
CLOZAPINE
CHEMBL42
Approved 1989
PERGOLIDE
CHEMBL531
Approved 1988
PERGOLIDE MESYLATE
CHEMBL1275
Approved 1988
BUSPIRONE
CHEMBL49
Approved 1986
PIMOZIDE
CHEMBL1423
Approved 1984
NOMIFENSINE
CHEMBL273575
Approved 1984
BROMOCRIPTINE
CHEMBL493
Approved 1978
DOPAMINE
CHEMBL59
Approved 1974
HALOPERIDOL
CHEMBL54
Approved 1967
THIORIDAZINE
CHEMBL479
Approved 1962
CYPROHEPTADINE
CHEMBL516
Approved 1961
IMIPRAMINE
CHEMBL11
Approved 1959
CHLORPROMAZINE
CHEMBL71
Approved 1957
PHENOXYBENZAMINE
CHEMBL753
Approved 1953
Assay Landscape

Assay Landscape

185
Total Assays
392
Tested Compounds
2
Assay Types
Binding — 103 assays, 392 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 25 97 6.8
tissue-based format 24 87 7.1
protein format 21 94 6.8
assay format 18 114 7.0
organism-based format 15 0
Functional — 82 assays, 43 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 48 7 5.4
tissue-based format 19 10 7.7
assay format 13 19 7.7
cell membrane format 2 7 7.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine